BRPI0519327A2 - processo de preparaÇço de salicilamida n-substituÍda, composto, uso do mesmo e composiÇço farmacÊutica - Google Patents

processo de preparaÇço de salicilamida n-substituÍda, composto, uso do mesmo e composiÇço farmacÊutica

Info

Publication number
BRPI0519327A2
BRPI0519327A2 BRPI0519327-3A BRPI0519327A BRPI0519327A2 BR PI0519327 A2 BRPI0519327 A2 BR PI0519327A2 BR PI0519327 A BRPI0519327 A BR PI0519327A BR PI0519327 A2 BRPI0519327 A2 BR PI0519327A2
Authority
BR
Brazil
Prior art keywords
salicylamide
unsubstituted
compound
pharmaceutical composition
preparation process
Prior art date
Application number
BRPI0519327-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Bernhard Riss
Ulrich Meier
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34090175&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0519327(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0519327A2 publication Critical patent/BRPI0519327A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26—Two oxygen atoms, e.g. isatoic anhydride

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0519327-3A 2004-12-16 2005-12-14 processo de preparaÇço de salicilamida n-substituÍda, composto, uso do mesmo e composiÇço farmacÊutica BRPI0519327A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0427603.6A GB0427603D0 (en) 2004-12-16 2004-12-16 Organic compounds
PCT/EP2005/013454 WO2006063821A1 (en) 2004-12-16 2005-12-14 Manufacture process of n-substituted salicylamides

Publications (1)

Publication Number Publication Date
BRPI0519327A2 true BRPI0519327A2 (pt) 2009-01-13

Family

ID=34090175

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0519327-3A BRPI0519327A2 (pt) 2004-12-16 2005-12-14 processo de preparaÇço de salicilamida n-substituÍda, composto, uso do mesmo e composiÇço farmacÊutica

Country Status (24)

Country Link
US (1) US8461385B2 (enExample)
EP (2) EP1838664B1 (enExample)
JP (1) JP5224816B2 (enExample)
KR (1) KR101287233B1 (enExample)
CN (1) CN101080384B (enExample)
AR (1) AR055007A1 (enExample)
AU (1) AU2005315850B2 (enExample)
BR (1) BRPI0519327A2 (enExample)
CA (1) CA2587213C (enExample)
ES (1) ES2547349T3 (enExample)
GB (1) GB0427603D0 (enExample)
GT (1) GT200500353A (enExample)
IL (1) IL183366A0 (enExample)
MA (1) MA29092B1 (enExample)
MX (1) MX2007007211A (enExample)
NO (1) NO338969B1 (enExample)
PE (1) PE20060740A1 (enExample)
PL (1) PL1838664T3 (enExample)
PT (1) PT1838664E (enExample)
RU (1) RU2404158C2 (enExample)
TN (1) TNSN07229A1 (enExample)
TW (1) TW200635880A (enExample)
WO (1) WO2006063821A1 (enExample)
ZA (1) ZA200703826B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101627011A (zh) 2005-09-19 2010-01-13 爱密斯菲尔科技公司 N-(5-氯水杨酰基)-8-氨基辛酸的二钠盐的晶形
PL2215047T3 (pl) 2007-11-02 2014-05-30 Emisphere Tech Inc Sposób leczenia niedoborów witaminy b12
CN109473182B (zh) * 2018-11-12 2021-10-19 北京北排科技有限公司 一种基于深度信念网络的mbr膜透水率智能检测方法
CA3141383A1 (en) * 2019-05-20 2020-11-26 Lonza Guangzhou Pharmaceutical Ltd. Method for preparation of carsalam
CN115260116B (zh) * 2022-08-19 2024-04-12 株洲壹诺生物技术有限公司 8-(2-羟基苯甲酰胺基)辛酸钠及苯并噁嗪-2,4-二酮和8-溴辛酸乙酯的制法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU382610A1 (ru) * 1968-07-08 1973-05-25 Способ получения амидов карбоновых кислот
DE60017888T2 (de) 1999-04-05 2006-01-19 Emisphere Technologies, Inc. Dinatrium-salze, monohydrate und ethanol-solvate
TR200200619T2 (tr) * 1999-06-25 2003-01-21 The Institutes For Pharmaceutical Discovery, Llc. İkame edilmiş fenoksiasetik asitler.
ES2386263T3 (es) 2000-03-21 2012-08-14 Emisphere Technologies, Inc. Método de preparación de salicilamidas alquiladas mediante un producto intermedio de dicarboxilato
US7262325B2 (en) 2000-06-02 2007-08-28 Emisphere Technologies, Inc. Method of preparing salicylamides
WO2003057650A2 (en) * 2002-01-09 2003-07-17 Emisphere Technologies, Inc. Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate
EP1299348B1 (en) * 2000-06-29 2008-04-09 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US7495030B2 (en) * 2000-09-06 2009-02-24 Emisphere Technologies, Inc. (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
US7049283B2 (en) * 2000-12-06 2006-05-23 Novartis Ag Pharmaceutical compositions for the oral delivery of pharmacologically active agents
JP4417113B2 (ja) * 2002-02-20 2010-02-17 エミスフェアー・テクノロジーズ・インク Ｇｌｐ−１分子の投与方法
US20050054557A1 (en) * 2002-05-09 2005-03-10 Goldberg Michael M. Compositions for delivering parathyroid hormone and calcitonin

Also Published As

Publication number Publication date
PL1838664T3 (pl) 2016-04-29
CN101080384B (zh) 2011-06-15
NO338969B1 (no) 2016-11-07
AR055007A1 (es) 2007-08-01
NO20073548L (no) 2007-09-17
TNSN07229A1 (en) 2008-11-21
IL183366A0 (en) 2007-09-20
GB0427603D0 (en) 2005-01-19
RU2404158C2 (ru) 2010-11-20
CN101080384A (zh) 2007-11-28
JP5224816B2 (ja) 2013-07-03
JP2008524142A (ja) 2008-07-10
EP2955171A1 (en) 2015-12-16
GT200500353A (es) 2006-07-17
MX2007007211A (es) 2007-08-15
RU2007126972A (ru) 2009-01-27
EP1838664B1 (en) 2015-07-15
TW200635880A (en) 2006-10-16
ES2547349T3 (es) 2015-10-05
ZA200703826B (en) 2008-08-27
US20090253811A1 (en) 2009-10-08
MA29092B1 (fr) 2007-12-03
AU2005315850A1 (en) 2006-06-22
KR20070086276A (ko) 2007-08-27
PE20060740A1 (es) 2006-09-04
CA2587213A1 (en) 2006-06-22
PT1838664E (pt) 2015-10-16
US8461385B2 (en) 2013-06-11
EP1838664A1 (en) 2007-10-03
WO2006063821A1 (en) 2006-06-22
AU2005315850B2 (en) 2009-11-05
KR101287233B1 (ko) 2013-07-17
CA2587213C (en) 2015-05-19

Similar Documents

Publication Publication Date Title
BR0211289A (pt) Derivados de dolastatina 10
TR200201874T2 (tr) Proteaz inhibitörleri olarak yeni bileşikler ve bileşimler.
BR0314113A (pt) Derivados de amino propanol
EA200200546A1 (ru) Устойчивый полиморф гидрохлорида n-(3-этинилфенил)-6,7-бис(2-метоксиэтокси)-4-хиназолинамина, способы его получения и фармацевтические применения
BR0112538A (pt) Sais estáveis de ácido o-acetilsalicìlico com aminoácidos básicos
BR0313160A (pt) Composto, composição farmacêutica, métodos para tratar uma condição e um neoplasmo suscetìvel em um animal em um animal, processo para preparar um composto e uso de um composto
BRPI0500585B8 (pt) processo para a síntese de ivabradina e sais de adição desta com um ácido farmaceuticamente aceitável
MX2022014444A (es) Sal de malato de n-(4-{[6,7-bis(metiloxi) quinolin-4-il] oxi}fenil)-n'-(4-fluorofenil) ciclopropano-1,1-dicarboxamida, y sus formas cristalinas para el tratamiento de cancer.
TNSN07228A1 (en) Manufacture process of organic compounds
UY27619A1 (es) Ésteres hidroxamato del ácido n-(4-fenil sustituido)- antranílico
BRPI0409465A (pt) derivados de carboxamida como agentes antidiabéticos
BR0117190A (pt) Composto, composição farmacêutica, uso do composto, e, processo para fabricá-lo
BRPI0519327A2 (pt) processo de preparaÇço de salicilamida n-substituÍda, composto, uso do mesmo e composiÇço farmacÊutica
BRPI0417609B8 (pt) derivados de 3-ciano-quinolina com atividade antiproliferativa, seu processo de preparação e uso e composição farmacêutica que os compreende
IL189015A0 (en) Crystalline forms of the di-sodium salt of n-(5-chlorosalicyloyl)-8-aminocaprylic acid
UY30048A1 (es) Derivados sustituidos de la n,2-(1h-benzimidazol-1-il) acetamida, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones
DK1255757T3 (da) Aminosyreforbindelser og deres anvendelse som inhibitorer for NEP, ACE og ECE
BR0214742A (pt) Polimorfo cristalino de cloridrato de venlafaxina e métodos para sua preparação
BR0115755A (pt) Processo para preparação de ácido 1-(aminometil) ciclohexano-acético
BR0307009A (pt) Sais estáveis de ácido o-acetilsalicìlico com aminoácidos básicos ii
AR045727A1 (es) Fluorocombretastatina y derivados de la misma
DE60300683D1 (de) Prucaloprid-n-oxid
DK1585728T3 (da) Iminosyrederivater som inhibitorer af matrix-metalloproteinaser
BR0010658A (pt) Formas cristalinas de sal de sódio de 5-cloro-2-metóxi-n-(2-(4metóxi-3-metilaminotiocarbon ilaminossulfonilfenil)etil)benzamida
MXPA03001985A (es) Cristales novedosos de n-hidroxi-2 (s) -metil-5 -etoximetoxi-4 (s)-[n -(4-fenoxifenilcarbonil) amino] pentamida, proceso para su produccion y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements